Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 349

1.

Select panicogenic drugs and stimuli induce consistent increases in tail skin flushes and decreases in core body temperature.

Federici LM, Caliman IF, Fitz SD, Shekhar A, Johnson PL.

Behav Pharmacol. 2018 Nov 21. doi: 10.1097/FBP.0000000000000440. [Epub ahead of print]

PMID:
30480550
2.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.

Schilling LP, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, de Mello Rieder CR, Gauthier S, Palmini A, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2018 Nov 9. doi: 10.1007/s12035-018-1405-1. [Epub ahead of print]

PMID:
30414086
3.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.

Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, Cash DM, Thomas DL, Dick KM, Cardoso J, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Warren JD, Crutch S, Fox NC, Ourselin S, Schott JM, Rohrer JD, Alexander DC; Genetic FTD Initiative (GENFI); Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Nat Commun. 2018 Oct 15;9(1):4273. doi: 10.1038/s41467-018-05892-0.

4.

Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease.

Huang SY, Hsu JL, Lin KJ, Liu HL, Wey SP, Hsiao IT; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2018 Sep 14;8(1):13807. doi: 10.1038/s41598-018-31794-8.

5.

Role of medial hypothalamic orexin system in panic, phobia and hypertension.

Abreu AR, Molosh AI, Johnson PL, Shekhar A.

Brain Res. 2018 Sep 8. pii: S0006-8993(18)30467-0. doi: 10.1016/j.brainres.2018.09.010. [Epub ahead of print]

PMID:
30205108
6.

Panic results in unique molecular and network changes in the amygdala that facilitate fear responses.

Molosh AI, Dustrude ET, Lukkes JL, Fitz SD, Caliman IF, Abreu ARR, Dietrich AD, Truitt WA, Ver Donck L, Ceusters M, Kent JM, Johnson PL, Shekhar A.

Mol Psychiatry. 2018 Aug 14. doi: 10.1038/s41380-018-0119-0. [Epub ahead of print]

PMID:
30108314
7.

PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSD.

Li LP, Dustrude ET, Haulcomb MM, Abreu AR, Fitz SD, Johnson PL, Thakur GA, Molosh AI, Lai Y, Shekhar A.

Transl Psychiatry. 2018 Aug 14;8(1):155. doi: 10.1038/s41398-018-0208-5.

8.

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images.

Lu D, Popuri K, Ding GW, Balachandar R, Beg MF; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2018 Apr 9;8(1):5697. doi: 10.1038/s41598-018-22871-z.

9.

Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states.

Mahjoub I, Mahjoub MA, Rekik I; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2018 Mar 7;8(1):4103. doi: 10.1038/s41598-018-21568-7.

10.

Biological Sexing of a 4000-Year-Old Egyptian Mummy Head to Assess the Potential of Nuclear DNA Recovery from the Most Damaged and Limited Forensic Specimens.

Loreille O, Ratnayake S, Bazinet AL, Stockwell TB, Sommer DD, Rohland N, Mallick S, Johnson PLF, Skoglund P, Onorato AJ, Bergman NH, Reich D, Irwin JA.

Genes (Basel). 2018 Mar 1;9(3). pii: E135. doi: 10.3390/genes9030135.

11.

Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer's disease pathogenesis.

Zhou X, Chen Y, Mok KY, Zhao Q, Chen K, Chen Y, Hardy J, Li Y, Fu AKY, Guo Q, Ip NY; Alzheimer’s Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1697-1706. doi: 10.1073/pnas.1715554115. Epub 2018 Feb 5.

12.

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.

Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP; Alzheimer’s Disease Neuroimaging Initiative (ADNI) Study Group; Neurologic Outcomes Research Group (NORG).

Anesthesiology. 2018 Apr;128(4):728-744. doi: 10.1097/ALN.0000000000002103.

PMID:
29389750
13.

Statistical tests and identifiability conditions for pooling and analyzing multisite datasets.

Zhou HH, Singh V, Johnson SC, Wahba G; Alzheimer’s Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1481-1486. doi: 10.1073/pnas.1719747115. Epub 2018 Jan 31.

14.

Immune loss as a driver of coexistence during host-phage coevolution.

Weissman JL, Holmes R, Barrangou R, Moineau S, Fagan WF, Levin B, Johnson PLF.

ISME J. 2018 Feb;12(2):585-597. doi: 10.1038/ismej.2017.194. Epub 2018 Jan 12.

15.

Induction of chronic migraine phenotypes in a rat model after environmental irritant exposure.

Kunkler PE, Zhang L, Johnson PL, Oxford GS, Hurley JH.

Pain. 2018 Mar;159(3):540-549. doi: 10.1097/j.pain.0000000000001124.

PMID:
29200178
16.

Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.

Risacher SL, Anderson WH, Charil A, Castelluccio PF, Shcherbinin S, Saykin AJ, Schwarz AJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2017 Nov 21;89(21):2176-2186. doi: 10.1212/WNL.0000000000004670. Epub 2017 Oct 25.

17.

In vivo staging of regional amyloid deposition.

Grothe MJ, Barthel H, Sepulcre J, Dyrba M, Sabri O, Teipel SJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2017 Nov 14;89(20):2031-2038. doi: 10.1212/WNL.0000000000004643. Epub 2017 Oct 18.

18.

Corrigendum: Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images.

Guo S, Lai C, Wu C, Cen G; Alzheimer's Disease Neuroimaging Initiative.

Front Aging Neurosci. 2017 Sep 5;9:293. doi: 10.3389/fnagi.2017.00293. eCollection 2017.

19.

APOE genotype and early β-amyloid accumulation in older adults without dementia.

Lim YY, Mormino EC; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2017 Sep 5;89(10):1028-1034. doi: 10.1212/WNL.0000000000004336. Epub 2017 Aug 9.

20.

Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation.

Bonaventure P, Dugovic C, Shireman B, Preville C, Yun S, Lord B, Nepomuceno D, Wennerholm M, Lovenberg T, Carruthers N, Fitz SD, Shekhar A, Johnson PL.

Front Pharmacol. 2017 Jun 9;8:357. doi: 10.3389/fphar.2017.00357. eCollection 2017.

21.

Application of Hyperspectral imaging to predict the pH, intramuscular fatty acid content and composition of lamb M. longissimus lumborum at 24h post mortem.

Craigie CR, Johnson PL, Shorten PR, Charteris A, Maclennan G, Tate ML, Agnew MP, Taukiri KR, Stuart AD, Reis MM.

Meat Sci. 2017 Oct;132:19-28. doi: 10.1016/j.meatsci.2017.04.010. Epub 2017 Apr 20.

PMID:
28551294
22.

Adding Recognition Discriminability Index to the Delayed Recall Is Useful to Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.

Russo MJ, Campos J, Vázquez S, Sevlever G, Allegri RF; Alzheimer's Disease Neuroimaging Initiative.

Front Aging Neurosci. 2017 Mar 10;9:46. doi: 10.3389/fnagi.2017.00046. eCollection 2017.

23.

Construction and Analysis of Weighted Brain Networks from SICE for the Study of Alzheimer's Disease.

Munilla J, Ortiz A, Górriz JM, Ramírez J; Alzheimer's Disease Neuroimaging Initiative.

Front Neuroinform. 2017 Mar 10;11:19. doi: 10.3389/fninf.2017.00019. eCollection 2017.

24.

Electroacupuncture Promotes Central Nervous System-Dependent Release of Mesenchymal Stem Cells.

Salazar TE, Richardson MR, Beli E, Ripsch MS, George J, Kim Y, Duan Y, Moldovan L, Yan Y, Bhatwadekar A, Jadhav V, Smith JA, McGorray S, Bertone AL, Traktuev DO, March KL, Colon-Perez LM, Avin KG, Sims E, Mund JA, Case J, Deng X, Kim MS, McDavitt B, Boulton ME, Thinschmidt J, Li Calzi S, Fitz SD, Fuchs RK, Warden SJ, McKinley T, Shekhar A, Febo M, Johnson PL, Chang LJ, Gao Z, Kolonin MG, Lai S, Ma J, Dong X, White FA, Xie H, Yoder MC, Grant MB.

Stem Cells. 2017 May;35(5):1303-1315. doi: 10.1002/stem.2613.

25.

Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer's Disease.

Hao X, Li C, Du L, Yao X, Yan J, Risacher SL, Saykin AJ, Shen L, Zhang D; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2017 Mar 14;7:44272. doi: 10.1038/srep44272.

26.

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease.

Huang M, Yang W, Feng Q, Chen W; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2017 Jan 12;7:39880. doi: 10.1038/srep39880.

27.

Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.

Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2017 Feb 7;88(6):569-576. doi: 10.1212/WNL.0000000000003585. Epub 2017 Jan 6.

28.

Improved synthetic route to quinoxyfen photometabolite 2-chloro-10-fluorochromeno[2,3,4-de]quinoline.

Johnson PL, Kister J, Thornburgh S.

Pest Manag Sci. 2017 Aug;73(8):1703-1708. doi: 10.1002/ps.4517. Epub 2017 Feb 1.

PMID:
28058778
29.

Self-reported impulsivity in Huntington's disease patients and relationship to executive dysfunction and reward responsiveness.

Johnson PL, Potts GF, Sanchez-Ramos J, Cimino CR.

J Clin Exp Neuropsychol. 2017 Sep;39(7):694-706. doi: 10.1080/13803395.2016.1257702. Epub 2016 Nov 28.

PMID:
27892808
30.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology.

Schmitz TW, Nathan Spreng R; Alzheimer's Disease Neuroimaging Initiative.

Nat Commun. 2016 Nov 4;7:13249. doi: 10.1038/ncomms13249.

31.

Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.

Zhang X, Mormino EC, Sun N, Sperling RA, Sabuncu MR, Yeo BT; Alzheimer’s Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6535-E6544. Epub 2016 Oct 4.

32.

Anxiogenic CO2 stimulus elicits exacerbated hot flash-like responses in a rat menopause model and hot flashes in postmenopausal women.

Federici LM, Roth SD, Krier C, Fitz SD, Skaar T, Shekhar A, Carpenter JS, Johnson PL.

Menopause. 2016 Nov;23(11):1257-1266.

33.

Morphometricity as a measure of the neuroanatomical signature of a trait.

Sabuncu MR, Ge T, Holmes AJ, Smoller JW, Buckner RL, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):E5749-56. doi: 10.1073/pnas.1604378113. Epub 2016 Sep 9.

34.

Corrigendum to "Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model" [Psychoneuroendocrinology 65 (2016) 127-137].

Federici LM, Caliman IF, Molosh AI, Fitz SD, Truitt WA, Bonaventure P, Carpenter JS, Shekhar A, Johnson PL.

Psychoneuroendocrinology. 2016 Nov;73:275. doi: 10.1016/j.psyneuen.2016.08.001. Epub 2016 Sep 3. No abstract available.

PMID:
27597729
35.

Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ.

Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS.

Pract Radiat Oncol. 2016 Sep-Oct;6(5):287-295. doi: 10.1016/j.prro.2016.06.011. Epub 2016 Jun 24.

36.

Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.

Xie JY, Chew LA, Yang X, Wang Y, Qu C, Wang Y, Federici LM, Fitz SD, Ripsch MS, Due MR, Moutal A, Khanna M, White FA, Vanderah TW, Johnson PL, Porreca F, Khanna R.

Pain. 2016 Sep;157(9):2124-40. doi: 10.1097/j.pain.0000000000000628.

37.

Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.

Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS.

J Clin Oncol. 2016 Nov 20;34(33):4040-4046. doi: 10.1200/JCO.2016.68.3573. Epub 2016 Oct 31.

38.

Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ.

Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS.

Ann Surg Oncol. 2016 Nov;23(12):3801-3810. Epub 2016 Aug 15. Review.

39.

Evaluation of Low versus High Volume per Minute Displacement CO₂ Methods of Euthanasia in the Induction and Duration of Panic-Associated Behavior and Physiology.

Hickman DL, Fitz SD, Bernabe CS, Caliman IF, Haulcomb MM, Federici LM, Shekhar A, Johnson PL.

Animals (Basel). 2016 Aug 2;6(8). pii: E45. doi: 10.3390/ani6080045.

40.

Polygenic risk of Alzheimer disease is associated with early- and late-life processes.

Mormino EC, Sperling RA, Holmes AJ, Buckner RL, De Jager PL, Smoller JW, Sabuncu MR; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Aug 2;87(5):481-8. doi: 10.1212/WNL.0000000000002922. Epub 2016 Jul 6.

41.

Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.

Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Pérez JM, Evans AC; Alzheimer’s Disease Neuroimaging Initiative.

Nat Commun. 2016 Jun 21;7:11934. doi: 10.1038/ncomms11934.

42.

A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer's disease.

Liu H, Zhou X, Jiang H, He H, Liu X; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2016 Jun 7;6:26712. doi: 10.1038/srep26712.

43.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.

Tan L, Wang HF, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2016 May 27;6:26027. doi: 10.1038/srep26027.

44.

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology.

Insel PS, Mattsson N, Mackin RS, Schöll M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust WJ, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 May 17;86(20):1887-96. doi: 10.1212/WNL.0000000000002683. Epub 2016 Apr 15.

45.

Large-deviation statistics of vorticity stretching in isotropic turbulence.

Johnson PL, Meneveau C.

Phys Rev E. 2016 Mar;93(3):033118. doi: 10.1103/PhysRevE.93.033118. Epub 2016 Mar 21.

PMID:
27078458
46.

Pre-clinical medical students' perceptions of their patient safety skills in a simulated emergency department.

Raymond-Dufresne É, Brazil V, Johnson PL, Nielson TL.

Emerg Med Australas. 2016 Jun;28(3):325-8. doi: 10.1111/1742-6723.12565. Epub 2016 Mar 15.

PMID:
26992140
47.

Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy.

Sundermann EE, Biegon A, Rubin LH, Lipton RB, Mowrey W, Landau S, Maki PM; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Apr 12;86(15):1368-1376. doi: 10.1212/WNL.0000000000002570. Epub 2016 Mar 16.

48.

Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.

Podhorna J, Krahnke T, Shear M, Harrison JE; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2016 Feb 12;8:8. doi: 10.1186/s13195-016-0170-5.

49.

Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment.

Shokouhi S, Mckay JW, Baker SL, Kang H, Brill AB, Gwirtsman HE, Riddle WR, Claassen DO, Rogers BP; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2016 Jan 15;8:2. doi: 10.1186/s13195-016-0172-3.

50.

Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model.

Federici LM, Caliman IF, Molosh AI, Fitz SD, Truitt WA, Bonaventure P, Carpenter JS, Shekhar A, Johnson PL.

Psychoneuroendocrinology. 2016 Mar;65:127-37. doi: 10.1016/j.psyneuen.2015.12.011. Epub 2015 Dec 18.

Supplemental Content

Loading ...
Support Center